We are live on ! Find out more
VAM

Visium Asset Management Portfolio holdings

AUM $1.43B
1-Year Est. Return 3.58%
This Fund
S&P 500
This Quarter Est. Return
+7.33%
1 Year Est. Return
-3.58%
3 Year Est. Return
+100.3%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$6.44B
AUM Growth
+$259M
Cap. Flow
+$227M
Cap. Flow %
3.52%
Top 10 Hldgs %
34.31%
Holding
1,318
New
461
Increased
339
Reduced
236
Closed
232

Top Buys

Rank Stock Value
1
AGN
Allergan Inc
AGN
+$330M
2
BKD icon
Brookdale Senior Living
BKD
+$93.7M
3
THC icon
Tenet Healthcare
THC
+$85.2M
4
ENDP
Endo International plc
ENDP
+$70.6M
5
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
+$64.3M

Top Sells

Rank Stock Value
1
BHC icon
Bausch Health
BHC
+$206M
2
CVS icon
CVS Health
CVS
+$122M
3
TEVA icon
Teva Pharmaceutical Industries Limited
TEVA
+$102M
4
MCK icon
McKesson
MCK
+$80.6M
5
PCRX icon
Pacira BioSciences
PCRX
+$45.1M

Sector Composition

Rank Sector Weight
1 Healthcare 53.08%
2 Miscellaneous 9.89%
3 Energy 6.47%
4 Consumer Discretionary 5.67%
5 Financials 4.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GD icon
301
General Dynamics
GD
$97B
$3.01M 0.05%
25,820
+13,338
+107% +$1.52M
TRN icon
302
Trinity Industries
TRN
$2.24B
$3.01M 0.05%
95,502
+78,553
+463% +$2.23M
MTZ icon
303
MasTec
MTZ
$17.9B
$2.99M 0.05%
+96,963
New +$3.65M
AVGO icon
304
Broadcom
AVGO
$1.62T
$2.95M 0.05%
+409,600
New +$2.75M
CL icon
305
Colgate-Palmolive
CL
$69.4B
$2.92M 0.05%
+42,840
New +$2.87M
INVX
306
Innovex International
INVX
$2.09B
$2.92M 0.05%
+26,739
New +$2.87M
BA icon
307
Boeing
BA
$166B
$2.89M 0.04%
+22,732
New +$2.97M
BV
308
DELISTED
Bazaarvoice, Inc.
BV
$2.88M 0.04%
365,213
+38,363
+12% +$268K
TIBX
309
DELISTED
TIBCO SOFTWARE INC
TIBX
$2.87M 0.04%
+142,440
New +$2.84M
GE icon
310
GE Aerospace
GE
$319B
$2.87M 0.04%
22,784
+11,975
+111% +$1.52M
NRX
311
DELISTED
NEPHROGENEX INC COM
NRX
$2.87M 0.04%
476,491
– –
BSX icon
312
Boston Scientific
BSX
$63.6B
$2.82M 0.04%
220,555
-2,283,648
-91% -$29.7M
USB icon
313
US Bancorp
USB
$96.9B
$2.81M 0.04%
64,964
+35,208
+118% +$1.47M
IM
314
DELISTED
Ingram Micro
IM
$2.81M 0.04%
96,256
+71,789
+293% +$2.02M
NGNE icon
315
Neurogene
NGNE
$674M
$2.8M 0.04%
14,940
– –
LAB icon
316
Standard BioTools
LAB
$271M
$2.8M 0.04%
95,200
-267,790
-74% -$8.58M
FCX icon
317
Freeport-McMoran
FCX
$99.6B
$2.79M 0.04%
+76,524
New +$2.62M
LBTYA icon
318
Liberty Global Class A
LBTYA
$3.58B
$2.79M 0.04%
76,406
+26,342
+53% +$923K
WSO icon
319
Watsco Inc
WSO
$12.5B
$2.78M 0.04%
+27,016
New +$2.73M
PCP
320
DELISTED
PRECISION CASTPARTS CORP
PCP
$2.77M 0.04%
10,958
+9,390
+599% +$2.4M
ALTR
321
DELISTED
Altera Corp
ALTR
$2.76M 0.04%
79,401
+25,743
+48% +$870K
AKAM icon
322
Akamai
AKAM
$15.1B
$2.76M 0.04%
+45,167
New +$2.51M
MPC icon
323
Marathon Petroleum
MPC
$115B
$2.76M 0.04%
70,602
+64,358
+1,031% +$2.85M
S
324
DELISTED
Sprint Corporation
S
$2.75M 0.04%
322,543
+150,884
+88% +$1.32M
ANDV
325
DELISTED
Andeavor
ANDV
$2.74M 0.04%
46,776
+41,849
+849% +$2.31M
11 12
13
14 15

Similar funds

FBNAT
FirstMerit Bank N.A. Trustee Akron, Ohio $1.24B AUM 5.12% 1-Year Est. Return
CPS
Counsel Portfolio Services Mississauga, Ontario, Canada $1.01B AUM 2.83% 1-Year Est. Return
LH
Lebenthal Holdings New York $806M AUM 2.13% 1-Year Est. Return
CPM
Chesapeake Partners Management Baltimore, Maryland $669M AUM 1.23% 1-Year Est. Return
VFS
VSR Financial Services Overland Park, Kansas $607M AUM 0.85% 1-Year Est. Return
ZA
Zweig Advisers Hartford, Connecticut $586M AUM 1.34% 1-Year Est. Return
FVFIGP
Flagship Ventures Fund IV General Partner Cambridge, Massachusetts $585M AUM
WA
Westport Advisers Westport, Connecticut $542M AUM 2.07% 1-Year Est. Return

Visium Asset Management's Q2 2014 Portfolio in Review

As of Q2 2014, Visium Asset Management held 1,318 positions worth $6.44B, up 4.2% from $6.18B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Visium Asset Management deployed $227M of net new capital in Q2 2014, opening 461 new positions and adding to 339 existing holdings. Its largest new stake was NPS PHARMACEUTICALS INC: 1,020,622 shares worth $33.7M.

By sector, the portfolio is most concentrated in Healthcare at 53% of assets, down from 56% a quarter earlier, followed by Miscellaneous and Energy.

On the sell side, the largest reduction was Bausch Health, an estimated $206M trimmed.

  • Visium Asset Management's largest Q2 2014 buy was NPS PHARMACEUTICALS INC: 1,020,622 shares worth $33.7M.
  • Visium Asset Management added most to Allergan Inc in Q2 2014, an estimated $330M increase.
  • Visium Asset Management's biggest Q2 2014 reduction was Bausch Health, cutting an estimated $206M.
  • Visium Asset Management fully exited QUESTCOR PHARMA INC in Q2 2014, selling an estimated $34M.
  • Visium Asset Management's ten largest holdings make up 34% of its $6.44B portfolio in Q2 2014.
  • Visium Asset Management opened 461 new positions and closed 232 in Q2 2014.
  • Visium Asset Management's portfolio value rose 4.2% quarter-over-quarter to $6.44B.

Based on Visium Asset Management's 13F filing for Q2 2014, filed 14 Aug 2014.